ID: MRFR/LS/3401-HCR | 110 Pages | Author: Kinjoll Dey | June 2023
Lung Function Tests Market Overview
The Lung Function Tests Market is expected to reach USD 7650 Million by 2030 at 7.5% CAGR during the forecast period 2022-2030. Lung function tests diagnose disorders related to the lungs like asthma, some respiratory infections, chronic obstructive pulmonary disease, and many more. Lung function tests determine the functioning of the lungs and also determine the breathing rate of a person. These are the part of the lung tests routines so performed by the pulmonary doctors. They suggest performing lung tests for diagnosing diseases related to the lungs. They plan the treatment and decide whether they will continue with it or change it or will not perform the treatment. Before the operation, the type of lung function test plays a vital role in diagnosing several respiratory diseases and lung-related disorders.
The pulmonary testing devices are used for the identification of pulmonary impairment and some respiratory issues. An increase in air pollution and some of the climatic changes have accelerated the business sector. These devices are used for testing the rate of flow, measuring the lung volume capacity, and used for exchanging gas. These systems are used for diagnosing some of the lung disorders and are used for selecting therapeutics related to disorders of the lungs.
COVID 19 ANALYSIS
The outbreak of COVID has hampered the ecosystem. It was marked that it majorly affected the respiratory system of the people. The most common symptoms observed by people who were affected by SARS CoV-2 are that they were unable to breathe properly and there was a lowering of oxygen level in them. The lung testing devices became a boom in the last year as these types of equipment were used for identifying the infection.
People throughout the world are suffering from this disease. This pandemic increased the demand for oxygen cylinders, testing kits, and ventilators. The government has discovered many applications that will help you to know whether you are affected by COVID or not. This has given a hike to the lung testing market.
MARKET DYNAMICS
MARKET SEGMENTATION
REGIONAL ANALYSIS
America is said to be the most dominant lung functioning market where advanced tests are performed. People here are mostly affected by various types of allergies. As per the American College of Allergy Asthma and Immunology, of the United States, it was marked that people here were mostly affected by allergic asthma, food allergy, and eczema. Moreover, it was found that 1 in every 12 people are suffering from allergic rhinitis all over America. The European market is said to be the second-largest market covering a major portion of lung function tests market share. Moreover, in some of the regions of Europe allergy has become more prominent. Mostly here people suffer from asthma, food allergy, and anaphylaxis. So due to the allergy reactions being more prominent, people undergo diagnostic services. The rise in awareness concerning the available treatments and skin testing propels up the lung function tests market size.
According to the European Academy of Allergy and Clinical Immunology, at least 150 million Europeans suffer from chronic disorders. The Asian Pacific region grows at a very rapid rate and is moreover driven by rising in asthmatic patients and an increase in the growth of the aging population. The rise in lung function tests market size also increases with the fuelling up of the environmental population. Weakening immune response of the body highly prevalent asthmatic disorders are the maximum risk factors for people suffering from allergic reactions among the high age population. COPD being the most famous disorder boosts up the market lung function tests market size steers up the market size. Some of the Middle Eastern regions along with African regions show an exponential growth curve in the overall pulmonary lung function tests market thus leading to the high prevalence of chronic diseases and enhancing the healthcare structure. As per the lung function, test market trends rise in demand for diagnostic services has an influential growth on the pulmonary lung function tests market growth, especially in this region.
COMPETITIVE LANDSCAPE
Some of the major key players playing in the lung function tests market are MGC Diagnostic Corporation of the United States, Perkin Eimer of the United States, COSMED Srl of Italy, CareFusion Corporation of the United States, General Electric Company, NIHON KOHDEN CORPORATION of Japan, and many more. These key players understood the competition going on in the market and provided a good analysis of the competitors. The competitive landscape includes the company's overview, the company's profile, and the portfolio of the key players.
REPORT OVERVIEW
Lung function tests market report gives good analysis and insights concerning the various factors which remain prevalent during the market forecast period. It gives information about its impact on the whole of the population. The report gives detailed information about the new and innovative recent developments, gives a good analysis of export and import business, about the units that occupy a good lung function, tests market share, gives analysis about the key players and many more. It gives information about the growth factors and the application niches, product launches and also gives information about the geographic and regional expansion. It also summarises the new and innovative technology.
Report Attribute/Metric | Details |
---|---|
Market Size | USD 7650 Million |
CAGR | 7.5% |
Base Year | 2021 |
Forecast Period | 2022-2030 |
Historical Data | 2020 |
Forecast Units | Value (USD Million) |
Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Segments Covered | Type, Indication, Devices |
Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
Key Vendors | CareFusion Corporation (U.S.), MGC Diagnostic Corporation (U.S.), General Electric Company (U.S.), Perkin Elmer (U.S), Carestream Health, Inc. (U.S.), COSMED srl (Italy), NIHON KOHDEN CORPORATION (Japan), and others. |
Key Market Opportunities | New product launches and R&D Amongst major key Players |
Key Market Drivers |
|
Some of them are the manufacturers of drugs for lung treatment, suppliers of drugs, investors investing certain sums on lung treatment, companies dealing with research and development, laboratories dealing with medical research, and also includes some of the providers dealing with market research and consulting services.
It gives a good analysis about the current and the future lung function tests market trends, some of the production sites, costs of the raw materials, and also about the investment done by the government.
The market gives a detailed analysis of the capital investment for improving the quality and growth of the market. The market has installed the infrastructural base for using different kinds of products for testing the devices in the market.
Key Questions Answered
Why Choose Market Research Future?